% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Mao:212552,
author = {Z. Mao and J. R. Baker and M. Takeuchi and H. Hyogo and A.
Tjønneland and A. K. Eriksen and G. Severi and J. Rothwell
and N. Laouali and V. Katzke$^*$ and R. Kaaks$^*$ and M. B.
Schulze and D. Palli and S. Sieri and M. S. de Magistris and
R. Tumino and C. Sacerdote and J. W. G. Derksen and I. T.
Gram and G. Skeie and T. M. Sandanger and J. R. Quirós and
M. Crous-Bou and M.-J. Sánchez and P. Amiano and S. M.
Colorado-Yohar and M. Guevara and S. Harlid and I. Johansson
and A. Perez-Cornago and H. Freisling and M. Gunter and E.
Weiderpass and A. K. Heath and E. Aglago and M. Jenab and V.
Fedirko},
title = {{P}re-diagnostic {S}erum {G}lyceraldehyde-{D}erived
{A}dvanced {G}lycation {E}nd {P}roducts and {M}ortality
{A}mong {C}olorectal {C}ancer {P}atients.},
journal = {International journal of cancer},
volume = {152},
number = {11},
issn = {0020-7136},
address = {Bognor Regis},
publisher = {Wiley-Liss},
reportid = {DKFZ-2023-00237},
pages = {2257-2268},
year = {2023},
note = {2023 Jun 1;152(11):2257-2268},
abstract = {Glyceraldehyde-derived advanced glycation end products
(glycer-AGEs) could contribute to colorectal cancer
development and progression due to their pro-oxidative and
pro-inflammatory properties. However, the association of
glycer-AGEs with mortality after colorectal cancer diagnosis
has not been previously investigated. Circulating
glycer-AGEs were measured by competitive ELISA.
Multivariable Cox proportional hazards models were used to
calculate hazard ratios (HRs) and corresponding $95\%$
confidence intervals (CIs) for associations of circulating
glycer-AGEs concentrations with CRC-specific and all-cause
mortality among 1,034 colorectal cancer (CRC) cases
identified within the European Prospective Investigation
into Cancer and Nutrition (EPIC) study between 1993 and
2013. During a mean of 48 months of follow-up, 529
participants died (409 from CRC). Glycer-AGEs were
statistically significantly positively associated with
CRC-specific (HRQ5 vs Q1 =1.53, $95\%CI:$ 1.04-2.25, Ptrend
=0.002) and all-cause (HRQ5 vs Q1 =1.62, $95\%CI:$
1.16-2.26, Ptrend <0.001) mortality among individuals with
CRC. There was suggestion of a stronger association between
glycer-AGEs and CRC-specific mortality among patients with
distal colon cancer (per SD increment: HRproximal colon
=1.02, $95\%CI:$ 0.74-1.42; HRdistal colon =1.51, $95\%CI:$
1.20-1.91; Peffect modification =0.02). The highest HR was
observed among CRC cases in the highest body mass index
(BMI) and glycer-AGEs category relative to lowest BMI and
glycer-AGEs category for both CRC-specific (HR=1.78,
$95\%CI:$ 1.02-3.01) and all-cause mortality (HR=2.15,
$95\%CI:$ 1.33-3.47), although no statistically significant
effect modification was observed. Our study found that
pre-diagnostic circulating glycer-AGEs are positively
associated with CRC-specific and all-cause mortality among
individuals with CRC. Further investigations in other
populations and stratifying by tumor location and BMI are
warranted. This article is protected by copyright. All
rights reserved.},
keywords = {Glyceraldehyde-derived advanced glycation end products
(Other) / advanced glycation end products (Other) /
colorectal cancer (Other) / mortality (Other) / prospective
study (Other)},
cin = {C020},
ddc = {610},
cid = {I:(DE-He78)C020-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:36715363},
doi = {10.1002/ijc.34449},
url = {https://inrepo02.dkfz.de/record/212552},
}